A B S T R A C T Human platelets and platelet particulate fractions were found to emit a burst of chemilumilinesceince during incubation with arachidonic acid. The magnitude of light emission was directly related to the number of platelets in the reaction mlixture and varied little for the same individual fromii day to day. The chemiiilunminescenice response of platelets vas localized to the particulate fraction aind was almiost totally oxygen dependent. In addition to arachidoniate, seven other polyunsaturated fatty acids, including several that are not prostaglandin precursors, also induced platelet chemiluminiescenice.
INTRODUCTION
Chemiluminescence (CL)1 has been reported to accompany a number of normal enzymatic reactions in Dr. Mills and Dr. Gerrard are recipients of Minnesota Heart Association Research Fellowship Awards.
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'Abbreviationis used in this paper: CL, chemiluminescence; C-PRP, citrate-platelet-rich plasma; HBSS, Hanks' balanced salt solution; PM N, polymorphonuclear neutrophils. biologic systems includinig lipid peroxidation of liver microsomiies (1-3) and adrenial mitochonidria (4) as well as phagocytosis in humani neutrophils (5, 6 ) and monocvtes (7, 8) . The photon emission of these CL reactions is thought to occur as a result of the decay of electronicallv excited species such as siniglet oxygeni or excited carbonyls. Thtus, light productioni serves as anl indicator of the presence of highly reactive, short-lived intermediate products present in these systems.
Recently, CL has been observed durinig the incuibation of arachidonic acid with sheep vesictular gland microsomiies (9) , a system knowni to support prostaglandin biosynithesis. Light emission was blocked by sinlglet oxygen scavengers aind by prostaglanidiin synthetase inhibitors and was felt to be related to anl early event in prostaglandini biosynthesis. We Inow report production of CL b1 the addition of arachidonic acid to human platelets and the relationship of light emission to platelet prostaglandin synthesis.
METHODS
Platelet preparation. To prepare washedl platelets or platelet-rich pla.sma, blood was obtained from normal donors who had not taken aspirin for 14 days. The blood was mixed immediately vith dextrose-citrate buffer, pH 6.5, in a ratio of nine parts blood to one part anticoagulant. Citrate-plateletrich plasma (C-PRP) was separated by centrifugation at 100 g for 20 mill at 22°C. Washed platelets were prepared by adding 1 ml 10% EDTA (0.343 M, pH 7.4) to 9 ml C-PRP, centrifuging at 1,1 10g in a Sorvall RC-2 (Ivan Sorvall, Inc., Norwalk, Conn.) for 10 min at 4°C, and resuspending the platelets in Hanks' balanced salt solution (HBSS; pH 7.4) to make a final volume of 10-ml separated platelets per 100 ml whole blood drawn. Final platelet count, monitored by Coulter counting (model B, Coulter Electronics Inc., Hialeah, Fla.), was 1.6-2.0 x 109 platelets per vial. Examination of final platelet preparations using a WNright stain showed that the total neutrophil contamination was 0.05% (1 x 1(5 polymorphonuclear neutrophils [PMN] per vial). Washed platelets and C-PRP were mainitained at 4°C until 5 mni before use when they were allowed to warm at room temperature. Platelets were used within 2-3 h after blood collectioni.
Particulate fraction of platelets. Platelet particulate fractions were prepared as described previously (10) The addition of arachidonic acid to suspensions of humaniaii platelets produced a burst of CL. The mean peak CL response of 35 adult volunteers is shown in Fig. 1 . The iimagnitude of light production varied widely amiiong the differenit donors but the same individuals varied little from lday to day, anid peak CL consistently occurred between 6 anid 30 s after insertion of the vial in the couniter (12-36 s after the additioni of arachidoniic acidl). The milagnitude of the CL responise for any particular donor was directly related to the number of platelets in the reactioni mixture when the coneeintration of arachlidloniic acid was held constant (Fig. 2) .
The CL response of the washed platelets of a know\n chroniic graniuloimiatouis disease patient was 130 x 10( Cpmll, a value entirely comparable to normiial platelet (lonors. This findinig would correlate witlh the observe(d normnal phagocvtosis-stimulatedinitrobluie tetrazoliutm reductioni 1w platelets from these patients (14) . The neutrophils fromii this patient procluced no measurable CL during phagocytosis of zymosani particles, an observatioin Stjernholm has also reported (12) .
In an attenmpt to localize the platelet CL response to a particular subcellular fraction, separated platelets and a platelet particulate fraction were prepared from equial volumes of homologous blood. As illustrated in Fig. 3 , a significant proportioni of the luminescenice was localized to the particulate fraction. Arachidonic acid was held at 8 gmol/vial.
Induction ofCL in platelets by otherfatty acids
In addition to arachidonic acid, eight other polyunsaturated fatty acids were studied in the same molar concentrations as arachidonic acid, and all were found to induce CL in platelets (Table i) . Four (15, 16) , but also a number of other polyunsaturated fatty acids were found to induce platelet CL, it was necessary to explore the possibility that CL was a nonspecific reaction, initiated by a nonenzymatic substance in platelets during platelet-fatty acid incubation. When separated platelets suspended in HBSS were placed in a boiling water bath (1000C) for 5 min before the addition of arachidonate, CL was reduced to 13% of control (Table II) . These results suggest that almost 90% of the CL induced in platelets by arachidonate (and possibly by other polyunsaturated fatty acids) could be enzyme dependent.
Polyunsaturated fatty acids are extremely susceptible to auto-oxidation and could generate light-produc- ing species under certain experimental conditions. Inasmuch as arachidonic acid alone produced virtually no measurable CL (Table II) , the possibility that spontaneous generation of CL from fatty acid oxidation was contributing to platelet CL was eliminated. However, the possibility that fatty acid auto-oxidation gave rise The complete absence of detectable neutrophil CL in our platelet preparations may be due in part to neutrophil damage sustained by the more vigorous centrifugation used in the platelet preparation procedure. When neutrophils were prepared for particle-induced neutrophil CL (protocol II, Methods), there was no measurable increase in CL upon addition of 5 x 105 of these PMN to platelet preparations. However, there was a 10% increase in platelet CL wlhen platelet-leukocyte contamination was increased 10-fold by adding 5 x 106 of these PMN to the reaction mixtures.
The lack of detectable neutrophil CL in our platelet preparation is also largely due to the fact that neuitrophils in this study are exposed to polytunsaturated fatty acids rather than target particles that induce phagocy- (Fig. 4) . All reaction mixtures were prepared from the same platelet prepara- tion. The reactioni miixture, in which oxygen was largely replaced by gaseouis nitrogen (Fig. 4, curve 2) , was obtaiimed b.y degassing the b1uffer with initrogen for 20 min, addinig the platelets to the buffer, and degassing that nmixtture as well. Dturing the addition of arachidoinic acid at 0 time, the reaction mixture was briefl exposed to atmospheric conditionis. Thuis, the system was not maintained entirely oxygen-free, and this may account for the small amounit of CL produced. To demonstrate that the platelets were not damiiaged or iniactivated by the nitrogeni, ain oxygen-depleted reaction mixture prepared as above was allowed to equiilibrate with room air for 30 min. WNhen arachlidoniic acid was added to these platelets, light produiction was normiial (Fig. 4,  curve 3 ).
Correlationi of prostaglandin synthesis atnd CL Aspirini inhibitioni of platelet CL. The iniflueniee of aspirin, a potent inhibitor of prostaglandiin svnthetase, on platelet CL, was sttu(lied bv incubatinig C-PRP with 100 ,uN. of aspirin at 222C for _20 mill. The platelets were separated from the plasmsa as usual and CL reactioin initiated with either arachidoniie acid or linoleic acid at 0 time. To examine whether aspirin was inhibiting platelet CL through a nonispecific effect rather than through the specific acetylation of cyclooxygenase (18) , two compounds of similar structure to aspirin, but lacking cyclooxygenase effect, were chosen as conitrols. When platelets were incubated with salicylic acid or sulfosalicvlic acid in the same concentrations and under the sanme conditionis as aspirin-treated platelets, there was virtually Ino detectable inhibition of CL (Fig. 5A) . These results would make a noinspecific effect of aspirin, stuch as metal chelation, highly unlikely. However, to confirimi and extend the evidence that aspirin inhibition of CL was specific inhibition of cyclooxygenase, we studied the platelets of a donor who had ingested two 300-mg tablets of acetylsalicylic acid 24 h previously The effect of aspirini ingestion on platelet CL is shownI in Fig. 5B . It is noteworthy that not only arachidonic acid-but linoleic acid-induced CL as well was markedly inhibited. Thus, it would appear that platelet CL induced by either the prostaglandin precursor, arachidonic acid, or by linoleic acid, which is not a prostaglandini precursor, involves the enzyme cyclooxygenase. As aspirin does not inhibit the conversion of arachidonic acid to 12-L-hvdroxy-5,8, 10,14-eicosatetraenoic acid via the lipoxygenase enzyme (19) , this finding would exclude the lipoxygenase reaction (20) from participating in platelet CL.
Malotndialdehyjde productiotn. When malondialdehyde productioni was used as an indication of platelet prostaglandin synthesis, a time-response curve of aspirini iinhibition of arachidonic acid-induced platelet CL closely paralleled a time-response curve of aspirin inhibitioi of malondialdehyde productioni (Fig. 6) . Similarly, the time-response curves of aspirin inhibition of platelet CL induced by linoleic acid closely paralleled that of arachidonic acid-induced platelet CL. There was incomplete inhibition by aspirin in both systems at the low concentration (10 ,utM) of aspirin chosen. No detectable malondialdehyde was found on inicubation of the linoleic acid with the platelets, a finding consisteint with this fatty acid not being converted to a prostaglandiin eind product. These results clearly implicate cyclooxygenase as the enzyme involved in arachidonic-iinduced platelet CL. They further demonstrate that linoleic acid, a polyunsaturated fatty acid that is not a prostaglaindin precursor, caii induce electronically excited species capable of light emission and that this light production maxy involve activation of prostaglaindin svnthetase. The effect of aspirin on platelet CL and malondialdehyde production. The reaction mixtures were prepared exactly as in Fig. 1 except that platelets were incubated with 10 ,uM aspirin for the indicated length of time before the addition of arachidonic or linoleic acid. Incubation was carried out for 5 min during which time CL was measured. Immediately after incubation, the reaction mixtures were assayed for malondialdehyde production. Each point represents a duplicate experiment. 12-36 s after platelet-arachidonate incubation, and decaying to base line within 1-2 min. This time-course is similar to that reported for fatty acid-induced CL of sheep vesicular gland microsomes (9) and the NADPHdependent microsomal lipid peroxidation systems (2, 3) , but occurs much more rapidly than human neutrophil CL (5, 7). The finding that the CL of the platelet system is almost entirely oxygen dependent is consistent with the findings in microsomal systems (2, 3) as well as for the CL of human leukocytes (5, 7) and rabbit macrophages (21) . Nakano and Sugioka (2, 3) showed by emission spectra that the luminescent species generated in their NADPH-dependent microsomal systems is 1Ag type singlet oxygen as well as other electronically excited molecules in the triplet state, probably carbonyls. These products are thought to be generated by a selfreaction of lipid peroxy radicals. Allen (5) postulated that singlet oxygen is generated in phagocytizing leukocytes by two potential methods: the nonenzymatic disproportionation of O2 and the reaction of the halidemyeloperoxidase-hydrogen peroxide system of the phagocyte. Allen proposed that the generated singlet oxygen, a potent electrophilic reactant, could attack electron-dense regions in unsaturated lipids, nucleic acid, and amino acid residues of the target microorganisms contained within the phagocytic vacuole. Oxidation of these substrates by singlet oxygen could generate electronically excited carbonyl groups which relax by means of photon emission. Spectral analyses of phagocytosing granulocytes by both Cheson et al. (6) and Lint et al. (22) were unable to support the contention that singlet oxygen per se is the major emitter in this system because distinctive singlet oxygen emissions could not be detected. Rather, the essentially "white light" nature of the spectrum was consistent with oxidation of a variety of particle constituents producing a heterogenous group of electronically excited species. The investigators (6) emphasize that their study provides no information as to whether or not singlet oxygen is generated by phagocytosing granulocytes, and that it is not only possible but even likely that singlet oxygen is produced by these cells.
In the present study, the specific nature of the excited species responsible for platelet CL was not identified. Platelets have recently been shown to produce superoxide in small amounts (23) . It was produced at a constant rate which did not increase after aggregation by agents such as collagen and thrombin. Platelet CL reported here was produced in a "burst" with light emission measurable in >6 s after the reaction was initiated by arachidonate, peaking in 12-36 s, and decaying to base line within 1-2 min. Platelet superoxide production was unaffected by prior ingestion of aspirin, indicating that the prostaglandin and thromboxane pathways are not involved. Platelet CL, on the other hand, was markedly inhibited by aspirin, and aspirin inhibition of the luminescence closely paralleled the time-course of aspirin inhibition of malondialdehyde production, findings which implicate the prostaglandin pathway. Thus, there is no evidence from these two studies to suggest that the superoxide radical is involved in the generation of platelet CL. On the other hand, the present study provides no information as to whether or not superoxide is involved in platelet CL emission.
The present study has evaluated the relationship between arachidonic acid-induced platelet CL and platelet prostaglandin biosynthesis. Evidence that these two events are related comes from several findings. Both events are found in the same subcellular fraction. In the present study, a significant proportion of platelet CL was localized in platelet particulate fraction. Previously, we have reported (24) that prostaglandin synthesis occurs in this subcellular fraction. Further evidence that platelet CL and prostaglandin synthesis are related is the finding that both are strictly oxygen dependent. This oxygen dependency, plus the very early "burst" in light emission, would be consistent with a light-emitting species participating in the oxidation reaction of arachidonate, early in prostaglandin synthesis.
The most compelling evidence that platelet CL is related to the prostaglandin pathway and specifically involves the activation of cyclooxygenase comes from studies employiing aspirin inhibition (Figs. 5 and 6 ). (19) . However, the small proportion of CL not inhibited by aspirin, or by boiling the platelets, is not explained and appears due to a reaction separate from prostaglandin synthesis. In addition to arachidonic acid, eight other polyunsaturated fatty acids, only three of which are known to be prostaglandin precursors, induced platelet CL. Evidence that these fatty acids, particularly linoleic acid, which are not prostaglandin substrates, may specifically interact with prostaglandin synthetase comes from the studies of aspirin inhibition of linoleic acidinduced platelet CL. The addition of low concentrations of aspirin to platelet preparations markedly inhibited linoleic acid-induced CL (Fig. 5 ) in much the same manner as the inhibition noted for arachidonateinduced CL. Similarly, platelets from a donor who ingested aspirin 24 h previously had markedly reduced CL production in this system. Moreover, the timecourse of aspirin inhibition of linoleic acid-stimulated CL paralleled the aspirin inhibition of arachidonateinduced CL. These findings suggest that either linoleic acid undergoes a specific interaction with prostaglandin synthetase with the resultant conversion to an electronicallv excited species but without achieving a final conversion to prostaglanidin, or it initeracts with a separate platelet enzyme (inhibitable by aspirin) to produce CL. This finding may have implications for the mechlainisnm bv which linoleic acid inhibits the conversioni of arachidoinic acid to prostaglandin endoperoxides aind throniboxanie A. (25) .
